In breast cancer, TAMs respond to a stiff fibrotic tumor microenvironment by initiating a TGF-β-directed collagen biosynthesis program and further impair CD8+ T cell function by altering amino acids, thereby modifying the immune microenvironment64. Here, TGFB1 is linked to neoplasm.